A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/407 (2006.01)
Patent
CA 2263499
A method for treating central nervous system associated with HIV infection is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4- [N,N'-1,1'-((2''-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-butane)-bis-(3,3'- indolyl)]-1(H)-pyrrole-2,5-dione hydrochloride salt.
Méthode de traitement du système nerveux central associé à des infections causées par le virus de l'immunodéficience humaine (HIV), notamment au moyen de l'inhibiteur protéine kinase c (PKC) à sélectivité d'isoenzyme, sel chlorhydrate de (S)-3,4-[N,N'-1,1'-((2''-éthoxy)-3'''(0)-4'''-(N,N-diméthylamino)-butane)-bis-(3,3'-indoly1)]-(H)-pyrrole-2,5-dione.
Jirousek Michael R.
Stramm Lawrence E.
Ways Douglas K.
Eli Lilly And Company
Smart & Biggar
LandOfFree
Use of inhibitors of pkc for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of inhibitors of pkc for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of pkc for the manufacture of a medicament... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2042300